X4 PHARMACEUTICALS, INC (XFOR) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -183.45%.
- 2026-03-31: Pre-Tax Margin -747.45%.
- 2025-12-31: Pre-Tax Margin -931.66%.
- 2025-09-30: Pre-Tax Margin -1690.93%.
Complete source-backed pre-tax margin history.
- Available history
- 2020-03-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -183.45% |
| 2026-03-31 | -747.45% |
| 2025-12-31 | -931.66% |
| 2025-09-30 | -1690.93% |
| 2025-06-30 | -1302.79% |
| 2025-03-31 | 1.10% |
| 2024-12-31 | -2758.93% |
| 2024-09-30 | -6550.18% |
| 2024-06-30 | 16136.94% |
| 2020-03-31 | -366.33% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -225.44% |
| 2024-12-31 | -1452.48% |
| 2020-12-31 | -2066.10% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |